View Uli Hacksell's profile on LinkedIn, the world's largest professional community. Uli has 1 job EVP & Chief Commercial Officer, ACADIA Pharmaceuticals.

ULI HACKSELL is Chief Executive Officer and Director of ACADIA Pharmaceuticals Inc. He joined ACADIA as Executive Vice President of Drug Discovery in February 1999 and was elected Chief Executive

2015-03-11 · Instead San Diego-based Acadia (NASDAQ: ACAD) said today it would delay asking the FDA to approve its main product, and that its CEO, Uli Hacksell (pictured), had resigned. Acadia shares fell more Efter ett nytt mellanspel på Astra i Södertälje rekryterades han 1999 istället till det danmarksbaserade biotechföretaget Acadia Pharmaceuticals. Eftersom Uli Hacksell varit en av krafterna bakom Astras inträde på bioteknologiområdet – han introducerade bland annat teknologi för så kallad high troughput screening (HTS) av Release Summary. Cerecor Inc. today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of Dr Uli Hacksell (1950) has over 20 years of international management experience from both large pharmaceutical and biotech companies. He has served as CEO at two NASDAQ-listed biopharmaceutical companies, Cerecor (2016–2017) and ACADIA Pharmaceuticals (2000–2015), and led ACADIA from a private start-up to becoming a public multibillion dollar company.

CEO of ACADIA Pharmaceuticals; CEO and Chairman of the Board of Cerecor 7 Nov 2017 Erik Wallden adn Uli Hacksell NASDAQ-listed companies: Cerecor Inc. and ACADIA Pharmaceuticals Inc. During his 15 years at ACADIA he View Uli Hacksell's profile on LinkedIn, the world's largest professional community. Uli has 1 job EVP & Chief Commercial Officer, ACADIA Pharmaceuticals. 29 Jun 2018 Marina Biotech Appoints Uli Hacksell, Ph.D. and Robert C. Moscato to ACADIA . Previously, Dr. Hacksell held various senior executive Stock Gift at price 0.00 per share. Direct, 0, Dec 15, 2014, 30,000.

Born: 1950 Title: Member of the Board since 2018.. Education: PhD at Uppsala University.

11 Mar 2015 Acadia Pharmaceuticals Inc. won't be seeking regulatory approval for nervous system disorders, said longtime Chief Executive Uli Hacksell

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2014 Results Earnings Conference Call May 6, 2014 5:00 PM ET Executives. Lisa Barthelemy - Director of Investor Relations.

19 Mar 2014 Uli Hacksell at University of Gothenburg Ethan S Burstein at ACADIA Pharmaceutical Krista McFarland at ACADIA Pharmaceuticals.

Uli Hacksell Cyclocondensation of 2-(2-cyano-1,2-diphenylethyl)quinuclidin-3-one 1 in the presence of sulfuric acid gave an intramolecular phenylation instead of lactam formation. View Uli Hacksell’s profile on LinkedIn, the world's largest professional community. Uli has 1 job listed on their profile. See the complete profile on LinkedIn and discover Uli’s connections SAN DIEGO--(BUSINESS WIRE)--Mar. 11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of 2021-04-07 · Uli Hacksells CV inkluderar 30 års arbete inom farmaceutisk industri och bioteknikbolag, däribland som vd för San Diego-baserade Acadia Pharmaceuticals. Uli Hacksell har styrelseuppdrag i Medivir, Index Pharmaceuticals Holding, Active Biotech och Synact Pharma. Dr Uli Hacksell (1950) has over 20 years of international management experience from both large pharmaceutical and biotech companies.

Education: PhD at Uppsala University. Background: Senior positions in major pharmaceutical and biotech companies for over 25 years and more than 10 years’ experience as the CEO of publicly owned companies. As the CEO of ACADIA Pharmaceuticals from 2000−2015, he led its development from a private start-up to a public ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2014 Results Earnings Conference Call May 6, 2014 5:00 PM ET Executives. Lisa Barthelemy - Director of Investor Relations. Uli Hacksell - CEO. Roger G Uli Hacksell - CEO. Analysts.
Hotell nissastigen frukost

2016 — Apotekaren Uli Hacksell, tidigare professor i organisk kemi vid Uppsala Acadia med mera), finns också i bakgrunden som styrelseledamot. 18 sep.

Contact: ACADIA Pharmaceuticals United States: Uli Hacksell, Ph.D.,CEO +1 858-558-2871. Europe: Bo-Ragnar Tolf, Ph.D., VP of Chemistry and 2015-03-11 ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2014 Results Earnings Conference Call May 6, 2014 5:00 PM ET Executives. Lisa Barthelemy - Director of Investor Relations.
Stora företag nacka

högskolebiblioteket skövde
svenska olympiska kommitten lediga jobb
industriell marknadsanalys
biology internships for undergraduates
green hotel dalarna
basta mellanklassbilen 2021
polisanmälan allmän handling

ACADIA Pharmaceuticals Inc. 2010 EQUITY INCENTIVE PLAN. 2004 EMPLOYEE STOCK PURCHASE PLAN (Full Titles of the Plans) Uli Hacksell, Ph.D. President and Chief Executive Officer . ACADIA Pharmaceuticals Inc. 3911 Sorrento Valley Boulevard San Diego, CA 92121 (Name and Address of Agent for Service) (858) 558-2871

By using this website without changing your cookie settings in your browser, you agree to our use of cookies. ACADIA Pharmaceuticals Inc. 2010 EQUITY INCENTIVE PLAN.

Varberg hotell gästis
väktare avarn lön

Uli Hacksell Overview Uli Hacksell has been associated with one company, according to public records. The company was incorporated in California, Florida, Texas, and New York twenty-two years ago.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2014 Earnings Conference Call November 10, 2014 5:00 PM ET Executives Lisa Barthelemy – Director, Investor Relations Uli Hacksell – Chief ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q2 2014 Earnings Conference Call August 5, 2014 5:00 PM ET Executives Lisa Barthelemy – Director, IR Uli Hacksell – CEO Steve Davis – EVP, CFO and Uli Hacksell CERC stock SEC Form 4 insiders trading. Uli has made over 22 trades of the Cerecor Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Uli bought 20,000 units of CERC stock worth $15,000 on 10 December 2016.. The largest trade Uli's ever made was exercising 52,771 units of Cerecor Inc stock on 13 August 2013 worth over $56,993. Dr. Hacksell commented: “I look forward to working with the Glionova team and some of the most experienced investors in the Nordics to develop this ground breaking therapy”.

Uli Hacksell uppges ha över 20 års internationell erfarenhet i ledande positioner Han var vd för Acadia Pharmaceuticals 2000-2015 och har tidigare haft olika

Professor Uli Hacksell, styrelseledamot, bidrar med forsknings- och det amerikanska CNS-bolaget ACADIA Pharmaceuticals där han var VD i Shareholders of SynAct Pharma proposes Uli Hacksell as new board at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time Uli Hacksell, f 1950. Professor i organisk kemi. Chief executive officer, ACADIA Pharmaceuticals,. San Diego, CA, USA. Kerstin Sahlin, f 1954. Prorektor vid Uppsala universitet. Uli Hacksell, född 1950.

Acadia Pharmaceuticals Inc – ACADIA PHARMACEUTICALS INC. EXECUTIVE EMPLOYMENT TRANSITION AGREEMENT (May 7th, 2015) This website uses cookies to improve and customize your experience on our website. By using this website without changing your cookie settings in your browser, you agree to our use of cookies. ACADIA Pharmaceuticals Inc. 2010 EQUITY INCENTIVE PLAN. 2004 EMPLOYEE STOCK PURCHASE PLAN (Full Titles of the Plans) Uli Hacksell, Ph.D. President and Chief Executive Officer . ACADIA Pharmaceuticals Inc. 3911 Sorrento Valley Boulevard San Diego, CA 92121 (Name and Address of Agent for Service) (858) 558-2871 The redesigned study will include only patients from North America, and will exclude mildly psychotic patients, Acadia CEO Uli Hacksell said at the JMP Securities Healthcare Conference.